Delivery Order SPE2DR25D1017-SPE2DR26F9BVK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,140.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,132.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,949.47 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, classified as a child contract with no set-aside designation. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $11,705.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 12, 2025. This non-competitive, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,092.99 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation therapy medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This competitively awarded, non-set-aside contract was issued on November 17, 2025, with a ceiling value of $3,251.29 and an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its...
- The Defense Logistics Agency awarded a $15,998.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalant medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 5, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania will serve as the place of performance for this order. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,554.00 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). Issued on June 9, 2025, with an ultimate completion date of June 10, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $55,290.76 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in 60-dose units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BVKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,672.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation treatment for chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal healthcare vendor, particularly for military and veteran medical supply chains. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its prime indefinite delivery vehicle with DLA, AmerisourceBergen provides pharmaceutical support globally to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a strategic partner in federal medical procurement and military healthcare logistics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/18/25 |